Therapeutic Strategy in Low-Risk Papillary Thyroid Carcinoma–long-Term Results of the First Single-Center Prospective Non-Randomized Trial Between 2011 and …
A Czarniecka, M Zeman, G Wozniak… - Frontiers in …, 2021 - frontiersin.org
Optimal therapeutic strategy in low advanced papillary thyroid carcinoma (PTC) is still a
matter of debate. The management differs depending on the country. A prospective non …
matter of debate. The management differs depending on the country. A prospective non …
Predictive factors for non-small-volume central lymph node metastases (more than 5 or≥ 2 mm) in clinically node-negative papillary thyroid carcinoma
JB Wang, YY Sun, LH Shi, L Xie - Medicine, 2019 - journals.lww.com
The benefits of prophylactic central neck dissection (pCND) for treating patients with clinical
node-negative (cN0) papillary thyroid carcinoma (PTC) remain controversial. Lymph node …
node-negative (cN0) papillary thyroid carcinoma (PTC) remain controversial. Lymph node …
[HTML][HTML] The effect of neck dissection on quality of life in patients with differentiated thyroid cancer
RS Dimov - Gland surgery, 2013 - ncbi.nlm.nih.gov
Cervical lymph node metastases are very common in patients with differentiated thyroid
cancer (DTC). The overall long term survival rate in patients with DTC is higher than 90 …
cancer (DTC). The overall long term survival rate in patients with DTC is higher than 90 …
Occurrence of BRAF mutations in a Polish cohort of PTC patients-preliminary results
A Czarniecka, D Rusinek, E Stobiecka… - Endokrynologia …, 2010 - journals.viamedica.pl
Introduction: Genetic alterations involving the mitogen-activated protein kinase (MAPK)
pathway are frequently demonstrated in papillary thyroid cancer (PTC). BRAF (V600E), the …
pathway are frequently demonstrated in papillary thyroid cancer (PTC). BRAF (V600E), the …
加强分化型甲状腺癌的规范化治疗
刘永锋 - 中国普外基础与临床杂志, 2009 - cqvip.com
手术是治疗分化型甲状腺癌的重要手段和有效方法, 已在我国各级医院广泛开展.
但由于对疾病认识的不足和技术条件的限制, 分化型甲状腺癌的外科治疗在不同地区 …
但由于对疾病认识的不足和技术条件的限制, 分化型甲状腺癌的外科治疗在不同地区 …
Complication rates of central compartment dissection in papillary thyroid cancer
WYW Kwan, TL Chow, CY Choi… - ANZ Journal of …, 2015 - Wiley Online Library
Background The benefits of central compartment dissection (CCD) in papillary thyroid
carcinoma (PTC) are still debatable and should be weighed against its potential risks. We …
carcinoma (PTC) are still debatable and should be weighed against its potential risks. We …
甲状腺乳头状癌临床N0 患者颈部淋巴结处理
鄢丹桂， 张彬 - 中华耳鼻咽喉头颈外科杂志, 2012 - cqvip.com
甲状腺癌是头颈部常见的恶性肿瘤, 近年来, 甲状腺癌发病率每年递增约6%,
已经成为美国女性第6 位常见的恶性肿瘤” 0, 在15~ 24 岁年龄段中, 甲状腺癌患者占所有恶性 …
已经成为美国女性第6 位常见的恶性肿瘤” 0, 在15~ 24 岁年龄段中, 甲状腺癌患者占所有恶性 …
Bilateral and ipsilateral central neck dissection in total thyroidectomy: a long term comparison of complications
D Rosati, M Bononi, P Ruscito, M Radici… - Indian Journal of …, 2022 - Springer
The role of prophylactic central compartment neck dissection (CCND) in total thyroidectomy
(TT) is controversial in patients without clinically evident lymph nodes metastasis (cN0) …
(TT) is controversial in patients without clinically evident lymph nodes metastasis (cN0) …
甲状腺全切联合中央区淋巴结清扫术安全性的Meta 分析
潘烨， 郑起， 樊友本， 伍波， 韩晓东 - 中华内分泌外科杂志, 2010 - cqvip.com
目的评价同时行甲状腺全切和颈中央区淋巴结清扫术(CLND) 的安全性. 方法采用Mantel-
Haenszel 法对符合人选标准的7 篇文献行Meta 分析, 计算相对危险度. 结果7 个临床试验共有1 …
Haenszel 法对符合人选标准的7 篇文献行Meta 分析, 计算相对危险度. 结果7 个临床试验共有1 …
多灶性甲状腺乳头状癌的构成比变化及临床分析
单志东， 巩鹏， 王忠裕 - 国际外科学杂志, 2013 - cqvip.com
目的探讨甲状腺乳头状癌中多灶性甲状腺乳头状癌的构成比变化, 淋巴结转移及预后等临床特点
方法回顾性分析大连医科大学附属第一医院2002 年1 月-2011 年12 月首次诊断并接受手术 …
方法回顾性分析大连医科大学附属第一医院2002 年1 月-2011 年12 月首次诊断并接受手术 …